Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Maria Bonora

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Metabolic Syndrome and Related Disorders|August 24, 2016
Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver?Benedetta Maria Bonora, Gian Paolo Fadini
Current Opinion in Pharmacology|December 3, 2020
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gapsMattia Albiero, Benedetta Maria Bonora, Gian Paolo Fadini
Current Diabetes Reports|May 20, 2020
Euglycemic KetoacidosisBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Diabetologia|May 14, 2017
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting SystemGian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro
Acta Diabetologica|January 13, 2022
Response to Chia Siang Kow and colleaguesAngelo Avogaro, Benedetta Maria Bonora, Gian Paolo Fadini
Diabetes, Obesity & Metabolism|May 19, 2017
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literatureBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 6, 2020
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the EvidenceBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Cardiovascular Diabetology|February 12, 2021
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting systemBenedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2019
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical AspectsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Diabetes Care|October 31, 2020
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast ItalyBenedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Metabolic Syndrome and Related Disorders|August 24, 2016
Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver?Benedetta Maria Bonora, Gian Paolo Fadini
Current Opinion in Pharmacology|December 3, 2020
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gapsMattia Albiero, Benedetta Maria Bonora, Gian Paolo Fadini
Current Diabetes Reports|May 20, 2020
Euglycemic KetoacidosisBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Diabetologia|May 14, 2017
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting SystemGian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro
Acta Diabetologica|January 13, 2022
Response to Chia Siang Kow and colleaguesAngelo Avogaro, Benedetta Maria Bonora, Gian Paolo Fadini
Diabetes, Obesity & Metabolism|May 19, 2017
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literatureBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 6, 2020
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the EvidenceBenedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Cardiovascular Diabetology|February 12, 2021
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting systemBenedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2019
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical AspectsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Diabetes Care|October 31, 2020
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast ItalyBenedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, et al.
Pageof 5